Italy

Italy

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.7 (0.40 - 1) 2016 Modelled ECDC
0.5 (0.30 - 1) 2007 Survey/reported Cozzolongo R et al, 2009
0.8 (0.40 - 1.30) 2003 Survey/reported Pendino GM, 2005
0.7 (0 - 3.90) 2001 Survey/reported Floreani A, 2006
1.67 (1.26 - 2.17) 2015 Modelled WHO
0.6 (0.30 - 0.70) 2016 Modelled Razavi-Shearer et al, 2018
2.52 (2.49 - 2.54) 2013 Modelled Schweitzer et al, 2015
0.71 (0.62 - 0.80) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.76 (0.66 - 0.85) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.66 - 0.86) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.88) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.72 - 0.91) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.73 - 0.92) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.75 - 0.94) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.77 - 0.97) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.79 - 0.99) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.81 - 1.01) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.82 - 1.03) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.85 - 1.05) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.88 - 1.08) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.90 - 1.11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.02 (0.91 - 1.13) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.03 (0.92 - 1.14) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.94 - 1.15) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.07 (0.96 - 1.17) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.98 - 1.19) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.1 (0.99 - 1.21) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.11 (1 - 1.22) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.14 (1.03 - 1.25) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (1.06 - 1.29) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (1.09 - 1.32) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.22 (1.11 - 1.34) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.24 (1.12 - 1.36) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (1.13 - 1.38) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.28 (1.15 - 1.41) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.18 - 1.44) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.34 (1.20 - 1.48) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.66 - 0.85) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1 2020 Modelled CDA Foundation
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.61 (0.39 - 0.93) 2015 Modelled WHO
0.03 (0.02 - 0.03) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.04 (0.03 - 0.05) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.06) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.06) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.08) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.06 - 0.09) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.07 - 0.11) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.08 - 0.13) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.15) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.11 - 0.19) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.14 - 0.24) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.22 (0.17 - 0.29) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.27 (0.20 - 0.35) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.33 (0.28 - 0.39) 2020 Modelled WHO
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.8 (0.70 - 1) 2016 Modelled ECDC
0.9 (0.70 - 1) 2009 Survey/reported Spada E et al, 2014
0.8 (0.60 - 1) 2012 Survey/reported Ruffini E et al, 2014
Showing out of
Show more
Prisoners
Download
Value (%) Year Type Source
6.7 (5.20 - 8.40) 2002 Survey/reported Babudieri S et al, 2005
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
332,000 (202,000 - 430,000) 2016 Modelled Razavi-Shearer et al, 2018
430,090 (375,354 - 483,967) 2019 Modelled IHME, GBD 2019 (accessed 2020)
439,721 (384,369 - 495,502) 2019 Modelled IHME, GBD 2019 (accessed 2022)
441,741 (385,899 - 497,174) 2018 Modelled IHME, GBD 2019 (accessed 2022)
443,503 (387,293 - 498,306) 2017 Modelled IHME, GBD 2019 (accessed 2022)
458,918 (401,987 - 513,137) 2016 Modelled IHME, GBD 2019 (accessed 2022)
475,434 (418,888 - 528,429) 2015 Modelled IHME, GBD 2019 (accessed 2022)
481,465 (424,356 - 534,668) 2014 Modelled IHME, GBD 2019 (accessed 2022)
492,970 (434,891 - 547,159) 2013 Modelled IHME, GBD 2019 (accessed 2022)
506,696 (447,869 - 560,975) 2012 Modelled IHME, GBD 2019 (accessed 2022)
518,933 (459,120 - 574,897) 2011 Modelled IHME, GBD 2019 (accessed 2022)
525,494 (466,440 - 583,723) 2010 Modelled IHME, GBD 2019 (accessed 2022)
531,282 (473,293 - 588,571) 2009 Modelled IHME, GBD 2019 (accessed 2022)
541,662 (484,181 - 598,770) 2008 Modelled IHME, GBD 2019 (accessed 2022)
553,539 (495,660 - 611,375) 2007 Modelled IHME, GBD 2019 (accessed 2022)
563,654 (504,798 - 623,636) 2006 Modelled IHME, GBD 2019 (accessed 2022)
568,198 (508,040 - 628,390) 2005 Modelled IHME, GBD 2019 (accessed 2022)
570,523 (511,719 - 629,477) 2004 Modelled IHME, GBD 2019 (accessed 2022)
576,132 (517,145 - 635,826) 2003 Modelled IHME, GBD 2019 (accessed 2022)
583,861 (524,542 - 643,464) 2002 Modelled IHME, GBD 2019 (accessed 2022)
591,359 (531,446 - 650,153) 2001 Modelled IHME, GBD 2019 (accessed 2022)
596,054 (536,025 - 655,866) 2000 Modelled IHME, GBD 2019 (accessed 2022)
603,806 (542,915 - 664,011) 1999 Modelled IHME, GBD 2019 (accessed 2022)
619,101 (558,596 - 679,650) 1998 Modelled IHME, GBD 2019 (accessed 2022)
637,413 (576,660 - 697,192) 1997 Modelled IHME, GBD 2019 (accessed 2022)
654,156 (591,933 - 715,070) 1996 Modelled IHME, GBD 2019 (accessed 2022)
664,623 (600,488 - 727,822) 1995 Modelled IHME, GBD 2019 (accessed 2022)
672,531 (607,644 - 736,655) 1994 Modelled IHME, GBD 2019 (accessed 2022)
684,165 (616,294 - 750,830) 1993 Modelled IHME, GBD 2019 (accessed 2022)
698,366 (628,952 - 767,565) 1992 Modelled IHME, GBD 2019 (accessed 2022)
713,941 (641,960 - 786,075) 1991 Modelled IHME, GBD 2019 (accessed 2022)
729,702 (653,248 - 806,083) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.84 (2.52 - 3.19) 2019 Modelled IHME, GBD 2019 (accessed 2020)
5.03 (4.55 - 5.52) 1990 Modelled IHME, GBD 2019 (accessed 2022)
4.83 (4.37 - 5.31) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.57 (4.13 - 5.04) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.41 (3.99 - 4.87) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.18 (3.78 - 4.60) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.3 (3.88 - 4.74) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.13 (3.74 - 4.56) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.13 (3.74 - 4.55) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.14 (3.75 - 4.55) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.13 (3.73 - 4.55) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.04 (3.66 - 4.46) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.74 (3.39 - 4.12) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.9 (3.53 - 4.30) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.57 (3.21 - 3.93) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.34 (3 - 3.69) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.19 (2.87 - 3.55) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.07 (2.76 - 3.41) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.96 (2.66 - 3.29) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.88 (2.58 - 3.20) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.81 (2.53 - 3.13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.48 - 3.08) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.75 (2.48 - 3.07) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.75 (2.47 - 3.07) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.71 (2.42 - 3.03) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.67 (2.39 - 2.99) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.61 (2.33 - 2.92) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.39 - 3.03) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.7 (2.41 - 3.02) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.46 - 3.12) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.84 (2.52 - 3.19) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3,509 2016 Modelled WHO
2,854 (2,583 - 3,134) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2,741 (2,481 - 3,012) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2,595 (2,345 - 2,857) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2,432 (2,196 - 2,679) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2,500 (2,261 - 2,758) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2,362 (2,136 - 2,600) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2,333 (2,111 - 2,573) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2,336 (2,117 - 2,569) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2,330 (2,109 - 2,568) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2,334 (2,111 - 2,572) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2,290 (2,072 - 2,525) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2,137 (1,934 - 2,355) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2,219 (2,008 - 2,446) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2,048 (1,845 - 2,257) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,933 (1,737 - 2,137) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,863 (1,673 - 2,069) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,755 (1,574 - 1,946) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,805 (1,619 - 2,004) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,689 (1,518 - 1,881) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,716 (1,540 - 1,906) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,668 (1,500 - 1,860) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,669 (1,499 - 1,858) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,670 (1,498 - 1,862) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,645 (1,474 - 1,841) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,587 (1,413 - 1,773) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,626 (1,452 - 1,818) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,643 (1,465 - 1,834) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,633 (1,451 - 1,836) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,676 (1,488 - 1,884) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,714 (1,517 - 1,927) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,714 (1,517 - 1,927) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
13 (11 - 15) 1990 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 16) 1991 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 16) 1992 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 16) 1993 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 16) 1994 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 16) 1995 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 16) 1997 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 16) 1996 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 15) 1998 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 15) 2000 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 15) 1999 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 14) 2002 Modelled IHME, GBD 2019 (accessed 2022)
11 (9 - 13) 2003 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 15) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 11) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 11) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2010 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2013 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2015 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2018 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 12) 2019 Modelled IHME, GBD 2019 (accessed 2022)
9 (8 - 11) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2019 Survey/reported WHO/UNICEF
94 2020 Survey/reported WHO/UNICEF
94 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Proportion of persons living with HBV diagnosed

National
Download
Value (%) Year Type Source
29 2016 Modelled CDA Foundation

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
30 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
Source:
HBV elimination goal
Source:
HBV testing policy
None
Source:
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.1 (0.70 - 1.30) 2015 Modelled Blach et al, 2017
1.87 (1.51 - 2.30) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.87 (1.51 - 2.28) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.85 (1.50 - 2.26) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.82 (1.48 - 2.22) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.46 - 2.18) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.81 (1.48 - 2.21) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.88 (1.53 - 2.29) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.96 (1.60 - 2.39) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.03 (1.65 - 2.48) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.69 - 2.52) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.70 - 2.53) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.70 - 2.52) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.70 - 2.52) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.71 - 2.52) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.09 (1.72 - 2.52) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.14 (1.75 - 2.58) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.23 (1.84 - 2.70) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.35 (1.93 - 2.82) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.44 (2 - 2.93) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.48 (2.03 - 2.98) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (2.03 - 2.99) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (2.03 - 2.99) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.48 (2.02 - 2.99) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (2.01 - 2.98) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.44 (1.99 - 2.95) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.39 (1.96 - 2.90) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.32 (1.90 - 2.81) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.23 (1.83 - 2.70) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (1.74 - 2.57) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2 (1.64 - 2.43) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.78 (1.44 - 2.19) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.68 (0.54 - 0.82) 2020 Modelled Kondili et al, 2022
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.39 (0.38 - 0.40) 2018 Survey/reported Piffer et al, 2020
People who inject drugs (PWID)
Download
Value (%) Year Type Source
56.61 2016 Survey/reported EMCDDA
57.26 2015 Survey/reported EMCDDA
54 2014 Survey/reported EMCDDA
49.6 2013 Survey/reported EMCDDA
67.52 2012 Survey/reported EMCDDA
60.48 2010 Survey/reported EMCDDA
58.52 2009 Survey/reported EMCDDA
59.24 2008 Survey/reported EMCDDA
60.21 2007 Survey/reported EMCDDA
61.95 2006 Survey/reported EMCDDA
61.4 2005 Survey/reported EMCDDA
63.5 2004 Survey/reported EMCDDA
64.9 2003 Survey/reported EMCDDA
64.89 2002 Survey/reported EMCDDA
66.32 2001 Survey/reported EMCDDA
67.4 2000 Survey/reported EMCDDA
67.14 1999 Survey/reported EMCDDA
67.45 1998 Survey/reported EMCDDA
67.1 1997 Survey/reported EMCDDA
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.65 (0.44 - 1.58) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
5.9 (5.20 - 6.60) 2016 Modelled ECDC
2.6 (2 - 3.40) 2007 Survey/reported Cozzolongo R et al, 2009
6.5 (5.40 - 7.80) 2003 Survey/reported Pendino GM, 2005
10.2 (8 - 12.70) 2001 Survey/reported Floreani A, 2006
2 (1.60 - 7.30) 2014 Survey/reported Gower et al, 2014
2.43 2019 Modelled Jin et al. 2017
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.4 (0.30 - 0.50) 2012 Survey/reported Ruffini E et al, 2014
Men who have sex with men (MSM) Living with HIV
Download
Value (%) Year Type Source
4.4 (2.10 - 7.20) 2019 Modelled Jin et al. 2017
People who inject drugs (PWID)
Download
Value (%) Year Type Source
57.9 (52.50 - 63.30) 2014 Modelled Degenhardt L et al, 2017
60.5 (56.80 - 64) 2010 Survey/reported EMCDDA
64.33 2017 Survey/reported ECDC
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
64.3 2017 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
2.6 2019 Modelled Jin et al. 2017
Prisoners
Download
Value (%) Year Type Source
38 (35 - 41.20) 2002 Survey/reported Babudieri S et al, 2005
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
680,000 (455,000 - 1,641,000) 2015 Modelled Blach et al, 2017
1,093,900 (897,393 - 1,329,570) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1,157,250 (946,954 - 1,402,000) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1,214,640 (996,202 - 1,468,060) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1,263,390 (1,036,430 - 1,528,880) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1,300,570 (1,064,350 - 1,573,030) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1,323,380 (1,081,360 - 1,600,160) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1,335,800 (1,091,000 - 1,616,140) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1,343,370 (1,096,910 - 1,623,860) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1,347,130 (1,100,360 - 1,622,780) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1,348,300 (1,101,750 - 1,622,010) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1,348,100 (1,102,000 - 1,622,920) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1,328,980 (1,087,700 - 1,599,910) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1,283,040 (1,052,370 - 1,545,670) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1,228,000 (1,008,830 - 1,482,300) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1,182,630 (970,869 - 1,427,460) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1,164,400 (956,405 - 1,407,180) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1,168,340 (959,118 - 1,414,540) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1,176,140 (961,936 - 1,427,070) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1,184,860 (968,904 - 1,438,210) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,191,660 (973,113 - 1,448,220) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,193,460 (973,720 - 1,457,500) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,176,420 (959,232 - 1,433,930) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,138,150 (927,387 - 1,388,430) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,093,320 (890,300 - 1,330,310) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,057,350 (860,264 - 1,284,440) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,045,250 (850,828 - 1,269,380) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,061,770 (865,680 - 1,295,290) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,081,010 (878,737 - 1,319,930) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,087,730 (883,104 - 1,334,120) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,088,890 (883,078 - 1,335,280) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,074,970 (869,359 - 1,320,490) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
81,800 (54,700 - 197,000) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
13.3 (11.80 - 14.70) 2019 Modelled IHME, GBD 2019 (accessed 2020)
15.38 (14.17 - 16.63) 1990 Modelled IHME, GBD 2019 (accessed 2022)
15.67 (14.42 - 16.93) 1991 Modelled IHME, GBD 2019 (accessed 2022)
15.77 (14.47 - 17.04) 1992 Modelled IHME, GBD 2019 (accessed 2022)
15.95 (14.68 - 17.23) 1993 Modelled IHME, GBD 2019 (accessed 2022)
16.08 (14.82 - 17.32) 1994 Modelled IHME, GBD 2019 (accessed 2022)
15.84 (14.61 - 17.13) 1995 Modelled IHME, GBD 2019 (accessed 2022)
15.69 (14.46 - 16.96) 1996 Modelled IHME, GBD 2019 (accessed 2022)
15.53 (14.31 - 16.77) 1997 Modelled IHME, GBD 2019 (accessed 2022)
15.41 (14.24 - 16.70) 1998 Modelled IHME, GBD 2019 (accessed 2022)
15.29 (14.14 - 16.52) 1999 Modelled IHME, GBD 2019 (accessed 2022)
14.97 (13.83 - 16.20) 2000 Modelled IHME, GBD 2019 (accessed 2022)
14.27 (13.07 - 15.46) 2002 Modelled IHME, GBD 2019 (accessed 2022)
14.63 (13.46 - 15.81) 2001 Modelled IHME, GBD 2019 (accessed 2022)
13.76 (12.56 - 14.92) 2003 Modelled IHME, GBD 2019 (accessed 2022)
13.16 (11.94 - 14.37) 2004 Modelled IHME, GBD 2019 (accessed 2022)
12.66 (11.43 - 13.85) 2006 Modelled IHME, GBD 2019 (accessed 2022)
12.84 (11.60 - 14.02) 2005 Modelled IHME, GBD 2019 (accessed 2022)
12.63 (11.38 - 13.80) 2007 Modelled IHME, GBD 2019 (accessed 2022)
12.74 (11.44 - 13.91) 2008 Modelled IHME, GBD 2019 (accessed 2022)
12.88 (11.54 - 14.05) 2010 Modelled IHME, GBD 2019 (accessed 2022)
12.85 (11.49 - 14.01) 2009 Modelled IHME, GBD 2019 (accessed 2022)
12.98 (11.60 - 14.16) 2011 Modelled IHME, GBD 2019 (accessed 2022)
13.04 (11.62 - 14.23) 2012 Modelled IHME, GBD 2019 (accessed 2022)
12.86 (11.46 - 14.05) 2013 Modelled IHME, GBD 2019 (accessed 2022)
12.74 (11.34 - 13.93) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12.85 (11.39 - 14.06) 2015 Modelled IHME, GBD 2019 (accessed 2022)
12.4 (11.01 - 13.57) 2016 Modelled IHME, GBD 2019 (accessed 2022)
12.74 (11.32 - 14) 2017 Modelled IHME, GBD 2019 (accessed 2022)
13.07 (11.59 - 14.33) 2018 Modelled IHME, GBD 2019 (accessed 2022)
13.35 (11.77 - 14.68) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
10,470 2016 Modelled WHO
8,050 (7,096 - 8,856) 2019 Modelled IHME, GBD 2019 (accessed 2022)
8,050 (7,096 - 8,856) 2019 Modelled IHME, GBD 2019 (accessed 2020)
7,905 (7,007 - 8,662) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7,719 (6,858 - 8,483) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7,523 (6,682 - 8,238) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7,811 (6,923 - 8,542) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7,748 (6,896 - 8,468) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7,816 (6,969 - 8,542) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7,919 (7,057 - 8,637) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7,861 (7,027 - 8,576) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7,772 (6,962 - 8,476) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7,709 (6,897 - 8,410) 2009 Modelled IHME, GBD 2019 (accessed 2022)
7,596 (6,822 - 8,292) 2008 Modelled IHME, GBD 2019 (accessed 2022)
7,477 (6,734 - 8,167) 2007 Modelled IHME, GBD 2019 (accessed 2022)
7,436 (6,715 - 8,140) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7,486 (6,767 - 8,179) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7,614 (6,909 - 8,313) 2004 Modelled IHME, GBD 2019 (accessed 2022)
7,904 (7,211 - 8,568) 2003 Modelled IHME, GBD 2019 (accessed 2022)
8,149 (7,465 - 8,829) 2002 Modelled IHME, GBD 2019 (accessed 2022)
8,318 (7,651 - 8,992) 2001 Modelled IHME, GBD 2019 (accessed 2022)
8,485 (7,839 - 9,180) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8,644 (7,994 - 9,338) 1999 Modelled IHME, GBD 2019 (accessed 2022)
8,703 (8,043 - 9,427) 1998 Modelled IHME, GBD 2019 (accessed 2022)
8,768 (8,078 - 9,466) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8,857 (8,161 - 9,577) 1996 Modelled IHME, GBD 2019 (accessed 2022)
8,950 (8,257 - 9,679) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9,097 (8,384 - 9,798) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9,036 (8,315 - 9,759) 1993 Modelled IHME, GBD 2019 (accessed 2022)
8,945 (8,204 - 9,662) 1992 Modelled IHME, GBD 2019 (accessed 2022)
8,894 (8,187 - 9,612) 1991 Modelled IHME, GBD 2019 (accessed 2022)
8,734 (8,050 - 9,446) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
59 (54 - 64) 1990 Modelled IHME, GBD 2019 (accessed 2022)
61 (55 - 66) 1991 Modelled IHME, GBD 2019 (accessed 2022)
63 (58 - 69) 1992 Modelled IHME, GBD 2019 (accessed 2022)
68 (62 - 73) 1994 Modelled IHME, GBD 2019 (accessed 2022)
66 (60 - 72) 1993 Modelled IHME, GBD 2019 (accessed 2022)
67 (61 - 72) 1995 Modelled IHME, GBD 2019 (accessed 2022)
67 (61 - 73) 1996 Modelled IHME, GBD 2019 (accessed 2022)
67 (61 - 72) 1997 Modelled IHME, GBD 2019 (accessed 2022)
66 (60 - 71) 1998 Modelled IHME, GBD 2019 (accessed 2022)
68 (62 - 73) 1999 Modelled IHME, GBD 2019 (accessed 2022)
68 (62 - 73) 2000 Modelled IHME, GBD 2019 (accessed 2022)
66 (60 - 72) 2001 Modelled IHME, GBD 2019 (accessed 2022)
64 (58 - 70) 2002 Modelled IHME, GBD 2019 (accessed 2022)
61 (55 - 66) 2004 Modelled IHME, GBD 2019 (accessed 2022)
61 (55 - 66) 2003 Modelled IHME, GBD 2019 (accessed 2022)
59 (53 - 64) 2005 Modelled IHME, GBD 2019 (accessed 2022)
59 (53 - 64) 2006 Modelled IHME, GBD 2019 (accessed 2022)
60 (54 - 64) 2008 Modelled IHME, GBD 2019 (accessed 2022)
59 (52 - 63) 2007 Modelled IHME, GBD 2019 (accessed 2022)
61 (55 - 66) 2009 Modelled IHME, GBD 2019 (accessed 2022)
64 (57 - 69) 2010 Modelled IHME, GBD 2019 (accessed 2022)
65 (58 - 71) 2011 Modelled IHME, GBD 2019 (accessed 2022)
66 (59 - 72) 2012 Modelled IHME, GBD 2019 (accessed 2022)
66 (59 - 72) 2013 Modelled IHME, GBD 2019 (accessed 2022)
66 (58 - 72) 2014 Modelled IHME, GBD 2019 (accessed 2022)
63 (56 - 69) 2015 Modelled IHME, GBD 2019 (accessed 2022)
61 (53 - 66) 2016 Modelled IHME, GBD 2019 (accessed 2022)
62 (55 - 69) 2017 Modelled IHME, GBD 2019 (accessed 2022)
62 (55 - 69) 2018 Modelled IHME, GBD 2019 (accessed 2022)
63 (55 - 69) 2019 Modelled IHME, GBD 2019 (accessed 2022)
58 (54 - 62) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons initiating HCV treatment

National
Download
Value Year Type Source
30,161 2015 Survey/reported Agenzia Italiana el Farmaco, 2023
34,066 2016 Survey/reported Agenzia Italiana el Farmaco, 2024
44,660 2017 Survey/reported Agenzia Italiana el Farmaco, 2025
56,499 2018 Survey/reported Agenzia Italiana el Farmaco, 2026
36,348 2019 Survey/reported Agenzia Italiana el Farmaco, 2027
15,664 2020 Survey/reported Agenzia Italiana el Farmaco, 2028
14,481 2021 Survey/reported Agenzia Italiana el Farmaco, 2029
Showing out of
Show more

Cumulative number of persons treated for HCV

National (2015-2021)
Download
Value Year Type Source
231,879 2021 Survey/reported Agenzia Italiana el Farmaco, 2022

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
30 2017 Survey/reported EMCDDA, 2019

Proportion of persons living with HCV diagnosed

National
Download
Value (%) Year Type Source
44 2020 Modelled CDA Foundation
HBV National Action Plan
Source:
HBV elimination goal
Source:
HBV testing policy
None
Source:
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Some (11-30%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
1 (%)
2020
CDA Foundation
HCV (RNA/cAg+)
0.68 (%)
2020
(0.54 - 0.82(%))
Kondili et al, 2022

Survey/surveillance

HBV (HBsAg+)
0.5 (%)
2007
(0.3 - 1(%))
Cozzolongo R et al, 2009
HCV (anti-HCV)
2 (%)
2014
(1.6 - 7.3(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
1,714
2019
(1,517 - 1,927)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
8,050
2019
(7,096 - 8,856)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.33 (%)
2020, latest modelled
(0.28 - 0.39(%))
WHO

Prevalence PWID

HCV
64.33 (%)
2017, survey/surveillance
ECDC

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Download National Hepatitis Elimination Profile (N-HEP)

Latest news

View all

Action plan

View all

News

Action plans

Resources

Partners